Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.
暂无分享,去创建一个
D. Duggan | E. Jacobs | D. Conti | J. Baron | R. Haile | J. Figueiredo | P. Thompson | P. Campbell | M. Martínez | J. Poynter | E. Leroy
[1] David V Conti,et al. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. , 2010, Cancer research.
[2] J. Potter,et al. Genetic Variation in the Vitamin D Receptor (VDR) and the Vitamin D–Binding Protein (GC) and Risk for Colorectal Cancer: Results from the Colon Cancer Family Registry , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[3] R. Bostick,et al. Effects of Vitamin D and Calcium on Proliferation and Differentiation In Normal Colon Mucosa: a Randomized Clinical Trial , 2009, Cancer Epidemiology, Biomarkers & Prevention.
[4] F. Clavel-Chapelon,et al. Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[5] R. Hayes,et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. , 2009, Carcinogenesis.
[6] E. Brown,et al. The role of the calcium-sensing receptor in the development and progression of cancer. , 2009, Endocrine reviews.
[7] R. Bostick,et al. Effects of Vitamin D and Calcium Supplementation on Markers of Apoptosis in Normal Colon Mucosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2009, Cancer Prevention Research.
[8] E. Hitre,et al. Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population , 2008, BMC Cancer.
[9] Peter W. Laird,et al. Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening , 2008, Cancer Epidemiology Biomarkers & Prevention.
[10] C. Ulrich,et al. Genetic Variation in Calcium-Sensing Receptor and Risk for Colon Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[11] M. Haussler,et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. , 2008, Nutrition reviews.
[12] W. Grady,et al. Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.
[13] C. Davis. Vitamin D and cancer: current dilemmas and future research needs. , 2008, The American journal of clinical nutrition.
[14] P. Holt. New insights into calcium, dairy and colon cancer. , 2008, World journal of gastroenterology.
[15] Bingshu E. Chen,et al. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case–control study in Shanghai, China , 2008, Carcinogenesis.
[16] M. Lane,et al. Retinol Increases β-Catenin-RXRα Binding Leading to the Increased Proteasomal Degradation of β-Catenin and RXRα , 2007, Nutrition and cancer.
[17] M. Boehnke,et al. So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. , 2007, American journal of human genetics.
[18] John D Potter,et al. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[19] L. R. Howe. Rexinoids and Breast Cancer Prevention , 2007, Clinical Cancer Research.
[20] E. Jacobs,et al. Diet, gender, and colorectal neoplasia. , 2007, Journal of clinical gastroenterology.
[21] B. Necela,et al. Differential expression, distribution, and function of PPAR-γ in the proximal and distal colon , 2007 .
[22] David V Conti,et al. Testing association between disease and multiple SNPs in a candidate gene , 2007, Genetic epidemiology.
[23] I. Weinstein,et al. Synergistic effects of RXR&agr; and PPAR&ggr; ligands to inhibit growth in human colon cancer cells—phosphorylated RXR&agr; is a critical target for colon cancer management , 2007, Gut.
[24] Matthias Platzer,et al. SNPSplicer: systematic analysis of SNP‐dependent splicing in genotyped cDNAs , 2006, Human mutation.
[25] W. Lamph,et al. Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. , 2006, Cancer letters.
[26] S. Gabriel,et al. Efficiency and power in genetic association studies , 2005, Nature Genetics.
[27] E. Jacobs,et al. Vitamin D Activity and Colorectal Neoplasia: A Pathway Approach to Epidemiologic Studies , 2005, Cancer Epidemiology Biomarkers & Prevention.
[28] P. Morel,et al. Two colons‐two cancers: Paradigm shift and clinical implications , 2004, Journal of surgical oncology.
[29] P. Lakatos,et al. Relationship between serum calcium and CA 19-9 levels in colorectal cancer. , 2004, World journal of gastroenterology.
[30] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[31] Naisyin Wang,et al. Chemopreventive n-3 fatty acids activate RXRα in colonocytes , 2003 .
[32] R. Chandraratna,et al. Adenomatous Polyposis Coli (APC)-independent Regulation of β-Catenin Degradation via a Retinoid X Receptor-mediated Pathway* , 2003, Journal of Biological Chemistry.
[33] S. Humphries,et al. The 4830C>A polymorphism within intron 5 affects the pattern of alternative splicing occurring within exon 6 of the thrombopoietin gene. , 2003, Experimental hematology.
[34] G. Hendy,et al. Human Calcium-sensing Receptor Gene , 2002, The Journal of Biological Chemistry.
[35] B. Ohlsson,et al. The Expression of Retinoic Acid Receptors and the Effects in Vitro by Retinoids in Human Pancreatic Cancer Cell Lines , 2002, Pancreas.
[36] R. Evans,et al. Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.
[37] H. Harn,et al. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization , 1999, British Journal of Cancer.
[38] G. Isshiki,et al. Two mutations remote from an exon/intron junction in the β-hexosaminidase β-subunit gene affect 3’-splice site selection and cause Sandhoff disease , 1998, Human Genetics.
[39] P. Chambon,et al. Retinoic Acid Receptors Interact Physically and Functionally with the T:G Mismatch-specific Thymine-DNA Glycosylase* , 1998, The Journal of Biological Chemistry.
[40] M. Langman,et al. Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. , 1996, Cancer research.
[41] B. Necela,et al. Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon. , 2007, Physiological genomics.
[42] I. Weinstein,et al. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. , 2007, Gut.
[43] Naisyin Wang,et al. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. , 2003, Carcinogenesis.
[44] A. Tislér,et al. Calcium-sensing receptor A986S polymorphism in human rectal cancer , 2002, International Journal of Colorectal Disease.
[45] ummers,et al. CALCIUM SUPPLEMENTS FOR THE PREVENTION OF COLORECTAL ADENOMAS , 2000 .
[46] G. Isshiki,et al. Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease. , 1998, Human Genetics.
[47] S Greenland,et al. Re: "The impact of confounder selection criteria on effect estimation. , 1989, American journal of epidemiology.